Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ciba Corning Diagnostics was a prominent medical diagnostics company established in 1985 as a joint venture between Ciba-Geigy and Corning. The company specialized in the development and manufacture of automated clinical laboratory instruments and reagents, with a particular focus on blood gas analysis and immunodiagnostics. Its flagship product, the ACS:180, was a pioneering high-throughput system that utilized chemiluminescence technology to automate immunoassay testing. Following a series of corporate transitions, including becoming a wholly-owned subsidiary of Ciba-Geigy and later part of Chiron, the business was acquired by Bayer in 1998. Today, its technological legacy continues as part of Siemens Healthineers, which acquired Bayer's diagnostics division in 2006.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ciba Corning Diagnostics.